Related Experiment Video

Updated: Jul 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Brief report: respiratory syncytial virus activity--United States, 2005-2006

    MMWR. Morbidity and Mortality Weekly Report
    |December 1, 2006
    PubMed

    Insights

    Respiratory syncytial virus (RSV) causes severe respiratory infections in young children and vulnerable adults. Early season surveillance data indicates the 2006-2007 RSV season has begun, highlighting the need for vigilance.

    Area of Science:

    • Virology
    • Epidemiology
    • Public Health

    Background:

    • Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRTIs) in young children.
    • RSV also poses significant risks for older adults and individuals with compromised health conditions.
    • Transmission occurs through respiratory droplets, direct contact, and contaminated surfaces.

    Purpose of the Study:

    • To present preliminary data on RSV activity for the 2006-2007 season.
    • To summarize RSV trends from July 2005 to June 2006.
    • To inform healthcare providers about RSV diagnosis and prevention.

    Main Methods:

    • Surveillance data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) was analyzed.
    • Preliminary data covered the weeks of July 8 to November 18, 2006.
    • RSV trends were summarized for the preceding 12-month period.

    Main Results:

    • Preliminary data indicated the onset of the 2006-2007 RSV season.
    • RSV activity typically peaks during winter months in temperate climates.
    • Surveillance data provides insights into seasonal RSV patterns.

    Conclusions:

    • Healthcare providers should consider RSV in diagnosing LRTIs across all age groups.
    • Implementing isolation precautions is crucial to prevent nosocomial RSV transmission.
    • Immune prophylaxis should be considered for high-risk infants and children.

    More Related Videos

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

    An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

    Published on: December 10, 2013

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

    Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

    Published on: April 4, 2019

    Related Concept Videos

    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Common Respiratory Disorders01:31

    Common Respiratory Disorders

    Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
    Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    Acute Respiratory Failure-I01:21

    Acute Respiratory Failure-I

    Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
    Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...